Close

OVERVIEW
Empowering Healthier Lives

13

Brands

50+

Countries

7

Manufacturing Facilities

1,400

Employees Worldwide

Atrium Innovations is recognized around the world as an innovative leader in the development, manufacturing, and commercialization of science-based nutritional health products.

Atrium Innovations is headquartered in Montreal, Canada and we have offices and manufacturing plants around the globe. We are a vertically integrated company with seven manufacturing facilities in the U.S., Canada, Europe and Argentina.

Our Purpose

Empowering healthier lives.

our_purpose

our_aspiration

Our Mission

Be a global leader in vitamins, minerals and supplements with the largest and fastest growing brands in the markets and channels in which we choose to distribute, with a proven reputation for premium-quality, science-based, professionally recognized products.

Our Commitment

Atrium Innovations is dedicated to promoting the health and well-being of those in need by giving back to local and global charities through our “Growing Together” program.

our_commitment

Our History at a glance

[carousel_anything items=”1″ items_desktop_small=”1″ items_tablet=”1″ thumbnails=”arrows” autoplay=”10000″ stop_on_hover=”true”]

2014
HR-Diver-Our-Histotory
June Peter Luther appointed as President and CEO
February Acquisition of Atrium Innovations by a group backed by the Permira funds

2013
HR-Diver-Our-Histotory
October Atrium Innovations acquires a controlling interest in Mucos Pharma CZ s.r.o., the exclusive distributor of Wobenzym® products in Central and Eastern Europe.

2011
HR-Diver-Our-Histotory
August
 Acquisition of Enzimas S.A.
April Acquisition of Robert & Fils (Québec) Inc.

2010
HR-Diver-Our-Histotory
December
Acquisition of Seroyal
March Acquisition of Trophic Canada

2009
HR-Diver-Our-Histotory
September Acquisition of Garden of Life
January Acquisition of the Wobenzym© family of products manufacturing facility (EAB Enzym‐Arzneimittel‐Berlin GmbH)

2008
HR-Diver-Our-Histotory

December Acquisition of Nutri-Health and its family of brands
September Acquisition of the AOV brand (Orthos Europe BV)
May Atrium Innovations divests its Active Ingredients & Specialty Chemicals Division
February Acquisition of Orthica and its family brands (Multicare B.V.)

2007
HR-Diver-Our-Histotory

July Acquisition of Wobenzym© and its family of brands (Mucos Emulsions GMBH)
May Atrium Biotechnologies Inc. changes its name to Atrium Innovations Inc.
January Acquisition of a liquid-filled capsule manufacturing facility (AquaCap) and its Caplique technology

2006
HR-Diver-Our-Histotory

October Atrium Biotechnologies is spun-off completely from
AEterna Zentaris

September Acquisition of Douglas Laboratories Canada

2005
HR-Diver-Our-Histotory

December Acquisition of Douglas Laboratories
March Atrium becomes a publicly-traded company with an Initial Public Offering

2004
HR-Diver-Our-Histotory

March Acquisition of Pure Encapsulations, Inc.

2000
HR-Diver-Our-Histotory

Two private placements with SGF Soquia Inc. and Fonds de solidarité des travailleurs du Québec (FTQ)

1999
HR-Diver-Our-Histotory

December Atrium Biotechnologies Inc. is established as a separate subsidiary of Æterna Laboratories Inc. (now known as AEterna Zentaris Inc.). Both companies where founded by brothers, Eric and Luc Dupont.

[/carousel_anything]